Back to DS Daiwa Securities Group Inc.
NTLA
Showing 6 of 26 quarters
Position history for DSDaiwa Securities Group Inc.'s holdings in Intellia Therapeutics, Inc.
No. Daiwa Securities Group exited its NTLA (Intellia Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 7,536 shares worth $68,000. Daiwa Securities Group held NTLA in 25 quarterly 13F filings before exiting.
Final Value
$0
Final Shares
0
Total Value Change
-$60,000
Total Shares Change
-5,151
Quarter-by-Quarter History